Clinical Trial Update: Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD) [EARLY_Phase 1]

View source ↗

Summary

Phase 1 early trial evaluating responses to live attenuated influenza virus vaccination in chronic obstructive pulmonary disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Live Attenuated Influenza Virus (LAIV) (live attenuated influenza virus)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: COPD | EARLY_Phase 1 | Status: COMPLETED